Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

UK to Invest up to £2.8M in Bioscience Research

Published: Thursday, April 17, 2014
Last Updated: Thursday, April 17, 2014
Bookmark and Share
The investment in collaborative feasibility studies aims to stimulate innovation across four technology areas that will enable and underpin UK growth.

The Technology Strategy Board, Invest Northern Ireland (Invest NI) and Highlands and Islands Enterprise (HIE) are to invest up to £2.75m in collaborative feasibility studies to stimulate innovation across four technology areas that will enable and underpin UK growth: advanced materials; biosciences; electronics, sensors and photonics, and information and communications technology (ICT). 

Projects will be led by a small or micro company, in collaboration with one or more business or research partners, with expected costs of £50k to £150k and last from six to 15 months. 

The bioscience proposals should be focused on one or more of the specific elements below: 

Characterisation and discovery tools 

  • commercial application of sequencing technologies focusing on genomics 
  • integration and exploitation of phenotyping technologies 
  • integration of 'omics technologies, such as integrating metabolomic, proteomic, genomic and phenomic data collection and interpretation capabilities 
  • biological imaging systems, biosensors, probes/ markers, diagnostic platforms. 

Production and processing 

  • metabolic engineering 
  • novel manufacturing processes for biological products and novel biological production systems 
  • formulation and delivery approaches for biological products, including biopharmaceuticals and functional foods. 

 Bioinformatics 

  •  approaches to organising, filtering and interpreting biological data, including biological system modelling, data visualisation and user-centred design. 

Projects should be focused on early-stage technical opportunities that: 

  • contain a significant level of technical risk, in that there is some level of uncertainty about how the proposed technical approach will work in practice 
  • involve companies carrying out most (if not all) of the research in-house. Projects should build a technical evidence base to enable progression to larger-scale projects. 

This competition opens on 6 May 2014, and the deadline for applications is noon on 25 June 2014.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Targeting Fat to Treat Cancer
Researchers develop novel cancer treatment that halts fat synthesis in cells, stunting tumors.
NIH Study Finds Link Between Depression, Gestational Diabetes
Researchers at NIH have discovered that the depression in early pregnancy doubles risk for gestational diabetes, and gestational diabetes increases risk for postpartum depression.
Gut Pathogens Thrive on Body's Tissue-Repair Mechanism
Researcher have discovered that harm caused by pathogens in the intestinal tract benefit from immune system response to damaged intestinal lining.
Cancer's Taste for Fat
Researchers discovered signalling pathway for fat burning is disrupted in certain cancers.
‘Tracking Bugs’ Reveal Secret of Cancer Cell Metabolism
Unexpected finding shows instead of throwing away valuable nutrients, the cells squeeze out every last drop of energy.
Ginger Nano-Lipid Particles May Improve Cancer Treatment
Edible ginger-derived nano-lipids show promise for effectively targeting and delivering chemotherapeutic drugs used to treat colon cancer.
Genetic Diversity of Enzymes Alters Metabolic Individuality
ToMMo scientists have shown that genetic polymorphisms, structural location of mutation and effect for phenotype correlate with each other.
Absolute Quantification of Mitochondrial Metabolites
Scientists have developed a method to quickly isolate and systematically measure metabolite concentrations within mitochondria.
Vitamin C May Boost Leukemia Treatment
Studies show that supplementing an epigenetic cancer drug with vitamin C enhanced the drug's effectiveness.
Demonstrating LNP Delivery of CRISPR Components
Intellia has presented data demonstrating in vivo gene editing ising liquid nanoparticles (LNPs) to deliver CRISPR/Cas9.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!